At the IGTP TODAY
Germans Trias has taken part in a webinar to present the results for the research into heart disease funded by the 2014 edition of the La Marató de TV3 and Catalunya Radio. Doctors and researchers at Germans Trias received funding for five projects and some of the results are already in clinical use.
The pioneering surgery that took place last May at the Germans Trias Hospital. The bio-implant, based on umbilical cord stem cells, has been developed by the Cardiovascular Disease Research Group (ICREC) at Germans Trias, led by Antoni Bayés-Genís in a research line, which they have been pursuing for 10 years. The new therapy has been developed with the collaboration of the Blood and Tissue Bank (BST) and the Institute of Bioengineering of Catalonia (IBEC); this is the first step of the application in clinical practice and the group will continue to monitor safety and the capacity of cardiac tissue to recover
Cardiogenic shock is a possible complication of serious heart attack involving an associated mortality rate of approximately 50% of all cases. The combination of this new tool with existing methods renders precise and patient-specific decision-making possible. The research is being led by Dr. Antoni Bayés at Germans Trias and the Proteomics Unit of the CRG and UPF, under Dr. Eduard Sabidó
Researchers from the Heart Disease Research Group at the IGTP and the CIBER Cardiovascular Group both led by Dr Antoni Bayés prepare the way to optimize reparative cell therapy in heart failure patients. The study, carried out in conjunction with the Immunogenetics and Histocompatibility Laboratory and the Cell Therapy Unit of the Blood and Tissue Bank of Barcelona has studied the HLA allele and the frequency of haplotypes in a cohort of patients with heart failure as the first stage in optimizing future allogenic cell therapies for these patients.
Researchers have developed a new non-invasive probe to detect the presence of metallic stents and monitor their potential structural failures in models of coronary artery disease. The new probe, which has been successfully tested on a murine model, would enable the substitution of surgical controls in patients with stents with a simple outpatient procedure. The study results from a collaboration between researchers from the Germans Trias i Pujol Research Institute (IGTP), the University of Barcelona (UB) and Universitat Politècnica de Catalunya (UPC).
Researchers of the Cardiovascular Disease Group and the CIBERCV Group, led by Dr Antoni Bayés Genís, have advanced the study of prognostic markers for heart failure, a progressive disease and a public health problem of the first order. They have studied monocyte (a type of white blood cell) count and distribution in a cohort of 400 outpatients with heart failure with a view to showing their predictive value. The study has been published in PLoS One.
This summer 11 students, from Badalona, Barcelona and Mollet are carrying out the practical part of their research projects for Baccalaureate through the IGTP Summer Programme in conjunction with the Organizers of the Badalona Scientific Workshops for schools
Researchers from the CIBERCV group at the Germans Trias i Pujol Research Institute (IGTP) have developed and compared two scaffolds, made by tissue engineering techniques.
Researchers from the Heart Disease Research Group at the Germans Trias I Pujol Research Institute (IGTP) and researchers from the Spanish Biomedical Research Network for Cardiovascular Disease (CIBERCV) have analysed the degree of shortening of telomeres and its correlation with progression of cardiac insufficiency (CI) over a year. The results published in Journal of Translational Medicine indicate that telomere shortening in monocytes is probably not a biomarker for the progression of CI
Researchers from the IGTP carry out the first proteomic profiling for extracellular vesicles in patients with dilated cardiomyopathy
